Free CME & Resources on Infectious Diseases
Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are bloodborne and transmitted primarily through sexual contact and injection drug use (IDU). They have shared routes of transmission and therefore involve not only risk of infection for each of the three viruses but also coinfection. Studies have demonstrated increased liver-related deaths among coinfected individuals, which is a leading cause of death in HIV-infected individuals. Other complications include kidney disease, cardiovascular disease, metabolic disorders, and bone complications.
The goal of the CME Outfitters Infectious Disease Hub is to provide clinicians and patients with access to education in order to address the challenges in screening and treating patients with HIV and/or HBV/HCV. Links to dedicated patient education hubs offer tools to improve health literacy and engage patients to be active participants in their treatment plan.
Creating Action Steps for Linking Underserved Populations with Hepatitis C Care
|
In this CME Outfitters OnDemand webcast, expert faculty will discuss the many barriers to treating HCV in the IDU population, including stigma and established negative perceptions about people who inject drugs (PWID), with special attention paid to applying CDC universal screening guidelines to improve diagnosis and linkage to treatment, expanding treatment for HCV in primary care settings, and addressing disparities in HCV treatment initiation in underserved communities. |
Opening the Door to Trust: Discussing HIV Risk Assessment and Prevention with Adolescents
|
In this CME Outfitters webcast, expert faculty focus on the development of skills and strategies for opening the conversation with adolescents and young adults about sexual history and practices in order to improve the rate of HIV testing and PrEP initiation in these populations. |
Breaking Down the Barrier of HIV-Related Stigma: Health Care Disparities and Unconscious Bias
|
In part 1 of this CMEO podcast series, Breaking Down the Barrier of HIV-Related Stigma: Health Care Disparities and Unconscious Bias, join Drs. Dan Scales and Christina Madison as they discuss how pharmacists can overcome implicit bias in health care and support equitable PrEP access for all patients. |
New Horizons in HIV Prevention Education: A Closer Look at Novel Therapies
|
In part 2 of this CMEO podcast series, New Horizons in HIV Prevention Education: A Closer Look at Novel Therapies, join Drs. Milena Murray and Dan Scales as they review recent advances in HIV prevention products and address knowledge gaps in the HIV health care continuum. |
Starting the Conversation: HIV Testing and Initiating PrEP
|
In the final episode of this CMEO podcast series, Starting the Conversation: HIV Testing & Initiating PrEP, join Drs. Dan Scales and Kalumi Ayala-Rivera as they provide valuable guidance on engaging at-risk patients in informed and sensitive discussions regarding HIV testing and initiation of PrEP. |
Novel Approaches to Treating CMV Infection in People Receiving Solid Organ or Hematopoietic Stem Cell Transplantations
Participate Now
|
In this CMEO Snack, join expert faculty as they discuss best strategies to identify risk factors of CMV infection, recognize the impact of CMV on treatment outcomes, and ultimately develop balanced treatment plans for patients with CMV disease. |
Treatment Decisions for Patients with HCV and CKD
Participate Now
|
This CMEO BriefCase will introduce a complex HCV case involving a patient with HCV and chronic kidney disease (CKD). Join Drs. Nancy Reau and Anthony Martinez as they dive deeper into treatment and management considerations for such patients, focusing on screening, diagnosis, and risk factors as well as the epidemiology and shared pathobiology of HCV and CKD. |
Mitigating Progression of Liver Fibrosis in HIV/HCV Coinfection
Participate Now
|
This CMEO BriefCase will introduce a complex case involving treatment and management considerations for a patient with HIV and HCV. Join Drs. Nancy Reau and Christian Ramers as they explore the epidemiology and shared pathobiology of liver fibrosis in HIV/HCV, real-world data for available therapies, contraindicated agent combinations, and when and how to treat. |
Treatment Selection in a Patient with Decompensated Cirrhosis
Participate Now
|
This CMEO BriefCase will introduce a case involving the incorporation of routine surveillance for HCC in a patient with HCV. Join our faculty experts as they delve into the epidemiology and shared pathobiology of HCV and decompensated cirrhosis, identify compensated versus decompensated cirrhosis, and discuss surveillance strategies for HCC. |
Looking Ahead: Long-Term Implications of HIV Pre-Exposure Prophylaxis (PrEP) Treatment Decisions
|
In this CMEO BriefCase, we will meet Christine, a transgender woman who has been taking emtricitabine/tenofovir disoproxil fumarate (F/TDF) for 5 years and has become concerned with the discussions on social media about PrEP and its interactions with feminizing hormone therapy. Expert faculty will discuss this case and how to apply clinical trial data to decision-making for patients who are taking PrEP. |
Maintaining the Course: Practical Strategies for Achieving PrEP Goals and Navigating Comorbidities
|
In this CMEO BriefCase participants will meet Isaiah, a 24-year-old African American man who presents to his primary care provider with concerns that he may have contracted a sexually transmitted infection (STI). During the encounter, Dr. Kelley uncovers behaviors related to substance use that may increase Isaiah’s risk for contracting HIV. The case of Isaiah will serve as a springboard for an overview of best practices for discussing a patient’s sexual and substance use history, as well as introducing HIV prevention strategies that can lead to initiation of PrEP. |
As We Age: Considering the Impact of Renal Impairment When Choosing an HIV Pre-Exposure Prophylaxis (PrEP) Formulation
|
This CME Outfitters BriefCase will introduce Matthew, a 53-year-old Hispanic man who has type 2 diabetes and hypertension who originally dismissed HIV prevention strategies but after considering the risk and consequences of HIV infection is now open to discussion. This patient case will be used to highlight how best to engage older adults who are at risk for contracting HIV in discussions about HIV prevention strategies, including assessing and applying clinical trial data to decision-making for PrEP initiation. |
Resources for Clinicians
HIV
- CDC HIV PrEP Guidelines 2017
- Evidence of HIV Treatment and Viral Suppression in Preventing the Sexual Transmission of HIV
- Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women
- Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens
- Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men
- Evaluation Toolkit: Patient and Provider Perspectives of HIV Screening in Health Care Settings
- HIV Care Quality Toolkit: HEIDIS Measurements for Rural and Community Practices
HCV
- AASLD-IDSA Recommendations for Testing, Managing, and Treating HCV
- CDC Recommended Testing Sequence for Identifying HCV
- Recommendation Statement: Hepatitis C Virus in Adolescents and Adults_Screening – US Preventive Services Task Force
- Guide to Comprehensive Hep C Counseling and Testing
HIV-HCV Co-Infection
Resources for Patients
Discover additional accredited CME/CE activities and patient resources on the Virtual Education Hub.